Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yangxin Dingji Oral Solution is a Traditional Chinese Medicine (TCM) oral liquid developed and manufactured by Shandong Dong'e Ejiao. It is specifically indicated for the treatment of cardiac conditions, including palpitations and cardiac arrhythmia. The formulation is based on traditional principles of nourishing the heart (Yangxin) and stabilizing palpitations (Dingji). As a product of Shandong Dong'e Ejiao, a company renowned for its production of Colla Corii Asini (donkey-hide gelatin), the solution likely incorporates this ingredient along with other herbal components to address heart-qi and blood deficiencies. It is currently approved and marketed in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yangxin Dingji Oral Solution.